DOBUTAMINE IN DEXTROSE

Product NDC: 51662-1664
11-digit product format: 516621664
Labeler code: 51662
Product ID: 51662-1664_47bf8f3f-ee08-c235-e063-6394a90a96fb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: DOBUTAMINE IN DEXTROSE
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS
Labeler: HF Acquisition Co. LLC, DBA HealthFirst
Application: NDA020201
Marketing category: NDA
Marketing start: 2005-08-12
Substance: DOBUTAMINE HYDROCHLORIDE
Active strength: 100 mg/100mL
Pharmacologic classes: Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOBUTAMINE HYDROCHLORIDE	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19
N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOBUTAMINE HYDROCHLORIDE	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19
N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOBUTAMINE HYDROCHLORIDE	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19
N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	DOBUTAMINE HYDROCHLORIDE	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
N020201-001	AP
N020201-002	AP
N020201-003	AP
N020201-006	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020201-001	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 200MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-002	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 100MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-003	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 50MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1993-10-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-006	DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER	EQ 400MG BASE/100ML	INJECTABLE / INJECTION	AP	RLD, RS	1994-07-07	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020201-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020201-006	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020201-006	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020201-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020201-006	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020201-006	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020201-006	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020201-006	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020201-006	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020201-006	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020201-006	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020201-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-003	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020201-006	AP	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: DOBUTAMINE IN DEXTROSE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOBUTAMINE HYDROCHLORIDE	100 mg/100mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0WR771DJXV	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
309985	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
3418aa46-2d9a-39f3-e063-6294a90a2961	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c061d745-4e41-be68-87e9-bad2cb726830	Product name	2	20240208
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
020518de-5dfd-f3a9-9c93-8015dad30497	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51662-1664-1	DOBUTAMINE IN DEXTROSE	250 mL in 1 BAG	INJECTION, SOLUTION	250		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51662-1664	DOBUTAMINE IN DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO. LLC, DBA HEALTHFIRST]	1	Current NDC, 1 package rows	20250503_3418aa46-2d9a-39f3-e063-6294a90a2961.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DOBUTAMINE IN DEXTROSE	DOBUTAMINE IN DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	559367ef-5c20-99ea-e063-6294a90a4ff2	2026-07-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020201 application number: NDA020201
Dobutamine in Dextrose	DOBUTAMINE IN DEXTROSE	Hospira, Inc.	9943a961-3b50-4847-8a84-d8414ce38daa	2026-06-03	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020201 application number: NDA020201
DOBUTAMINE IN DEXTROSE	DOBUTAMINE IN DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	52f70858-7cf9-2ff1-e063-6294a90ac46c	2026-05-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020201 application number: NDA020201
DOBUTAMINE IN DEXTROSE	DOBUTAMINE IN DEXTROSE	HF Acquisition Co. LLC, DBA HealthFirst	3418aa46-2d9a-39f3-e063-6294a90a2961	2026-01-06	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020201 application number: NDA020201 ndc (product): 51662-1664
DOBUTAMINE	DOBUTAMINE	HF Acquisition Co LLC, DBA HealthFirst	85fb5ba6-3597-e09f-e053-2a91aa0aded5	2024-01-28	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020201 application number: NDA020201

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0WR771DJXV	DOBUTAMINE HYDROCHLORIDE	49745-95-1	DOBUTAMINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309985	DOBUTamine 250 MG in 250 ML Injection	PSN	3418aa46-2d9a-39f3-e063-6294a90a2961	2
309985	250 ML dobutamine 1 MG/ML Injection	SCD	3418aa46-2d9a-39f3-e063-6294a90a2961	2
309985	dobutamine (as dobutamine HCl) 250 MG per 250 ML Injection	SY	3418aa46-2d9a-39f3-e063-6294a90a2961	2
309985	dobutamine 250 MG per 250 ML Injection	SY	3418aa46-2d9a-39f3-e063-6294a90a2961	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
51662-1664-1	51662166401	250 mL in 1 BAG (51662-1664-1)	250 ml	2005-08-12	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DOBUTAMINE IN DEXTROSE - HF Acquisition Co. LLC, DBA HealthFirst	HF Acquisition Co. LLC, DBA HealthFirst	2026-01-06	HUMAN PRESCRIPTION DRUG LABEL	2